Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
23.22
+0.32 (1.42%)
May 11, 2026, 10:06 AM EDT - Market open
Innoviva Employees
Innoviva had 159 employees as of December 31, 2025. The number of employees increased by 32 or 25.20% compared to the previous year.
Employees
159
Change (1Y)
32
Growth (1Y)
25.20%
Revenue / Employee
$2,645,849
Profits / Employee
$3,171,975
Market Cap
1.71B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Recursion Pharmaceuticals | 600 |
| Agios Pharmaceuticals | 540 |
| Ardelyx | 489 |
| Vericel | 398 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 307 |
| Viridian Therapeutics | 252 |
INVA News
- 4 days ago - Innoviva price target raised to $42 from $35 at BTIG - TheFly
- 4 days ago - Innoviva reports Q1 EPS $2.22 vs (74c) last year - TheFly
- 4 days ago - Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress - Business Wire
- 2 months ago - Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation's 2026 Antimicrobial Resistance Benchmark Report - Business Wire
- 2 months ago - 3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts - TipRanks
- 2 months ago - Innoviva Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Innoviva price target raised to $32 from $31 at Cantor Fitzgerald - TheFly
- 2 months ago - Innoviva reports Q4 EPS $1.94 vs. 26c last year - TheFly